These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25259414)

  • 1. Ab initio molecular simulations for proposing potent inhibitors to butyrylcholinesterases.
    Murakawa T; Matsushita Y; Suzuki T; Khan MT; Kurita N
    J Mol Graph Model; 2014 Nov; 54():54-61. PubMed ID: 25259414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors.
    Kos J; Kozik V; Pindjakova D; Jankech T; Smolinski A; Stepankova S; Hosek J; Oravec M; Jampilek J; Bak A
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
    Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
    Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Compounds for Butyrylcholinesterase Inhibition.
    Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M
    SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
    Saeed A; Zaib S; Ashraf S; Iftikhar J; Muddassar M; Zhang KY; Iqbal J
    Bioorg Chem; 2015 Dec; 63():58-63. PubMed ID: 26440714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific interactions and binding energies between thermolysin and potent inhibitors: molecular simulations based on ab initio molecular orbital method.
    Hirakawa T; Fujita S; Ohyama T; Dedachi K; Khan MT; Sylte I; Kurita N
    J Mol Graph Model; 2012 Mar; 33():1-11. PubMed ID: 22112671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes.
    Al-Aboudi A; Al-Qawasmeh RA; Shahwan A; Mahmood U; Khalid A; Ul-Haq Z
    Acta Pharmacol Sin; 2015 Jul; 36(7):879-86. PubMed ID: 25937631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.
    Karlsson D; Fallarero A; Brunhofer G; Mayer C; Prakash O; Mohan CG; Vuorela P; Erker T
    Eur J Pharm Sci; 2012 Aug; 47(1):190-205. PubMed ID: 22683890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
    Atatreh N; Al Rawashdah S; Al Neyadi SS; Abuhamdah SM; Ghattas MA
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1373-1379. PubMed ID: 31347933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors.
    Baumann K; Kordić L; Močibob M; Šinko G; Tomić S
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31382668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR, docking, dynamic simulation and quantum mechanics studies to explore the recognition properties of cholinesterase binding sites.
    Correa-Basurto J; Bello M; Rosales-Hernández MC; Hernández-Rodríguez M; Nicolás-Vázquez I; Rojo-Domínguez A; Trujillo-Ferrara JG; Miranda R; Flores-Sandoval CA
    Chem Biol Interact; 2014 Feb; 209():1-13. PubMed ID: 24321698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
    Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
    Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated in silico and experimental discovery of trimeric peptide ligands targeting Butyrylcholinesterase.
    Mukherjee RP; Yow GY; Sarakbi S; Menegatti S; Gurgel PV; Carbonell RG; Bobay BG
    Comput Biol Chem; 2023 Feb; 102():107797. PubMed ID: 36463785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular design and synthesis of novel peptides from amphibians skin acting as inhibitors of cholinesterase enzymes.
    Siano A; Garibotto FF; Andujar SA; Baldoni HA; Tonarelli GG; Enriz RD
    J Pept Sci; 2017 Mar; 23(3):236-244. PubMed ID: 28150445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery, biological evaluation and molecular dynamic simulations of butyrylcholinesterase inhibitors through structure-based pharmacophore virtual screening.
    Lu T; Liu Y; Liu Y; Chen H; Han C; Feng X; Zhou H; Li Y
    Future Med Chem; 2021 May; 13(9):769-784. PubMed ID: 33759552
    [No Abstract]   [Full Text] [Related]  

  • 17. Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation.
    Lu X; Yang H; Li Q; Chen Y; Li Q; Zhou Y; Feng F; Liu W; Guo Q; Sun H
    Bioorg Chem; 2019 Apr; 85():117-127. PubMed ID: 30605885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking studies and in vitro cholinesterase enzyme inhibitory activities of chemical constituents of Garcinia hombroniana.
    Jamila N; Yeong KK; Murugaiyah V; Atlas A; Khan I; Khan N; Khan SN; Khairuddean M; Osman H
    Nat Prod Res; 2015; 29(1):86-90. PubMed ID: 25219673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pteryxin - A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea.
    Orhan IE; Senol FS; Shekfeh S; Skalicka-Wozniak K; Banoglu E
    Food Chem Toxicol; 2017 Nov; 109(Pt 2):970-974. PubMed ID: 28286309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational and experimental studies on the interaction between butyrylcholinesterase and fluoxetine: implications in health and disease.
    Dalmizrak O; Teralı K; Yetkin O; Ogus IH; Ozer N
    Xenobiotica; 2019 Jul; 49(7):803-810. PubMed ID: 30052110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.